x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2015 > ESO Session: Is Innovation Affordable?
Print

ESO Session: Is Innovation Affordable?

Not eligible for ESCO credits

26.09.2015

Vienna, Austria

COURSES AND SEMINARS

General interest

Description

Chair: F.A. Peccatori, IT
Co-Chair: F. De Lorenzo, BE


The European School of Oncology is pleased to announce the session "Is Innovation Affordable?", which will be held during the European Cancer Congress 2015 (ECC2015) on Saturday 26 Septeber 2015 (
16:45-18:15, Hall A5) in Vienna, chaired by Dr. A. Costa and Mr. F. De Lorenzo.
Attendance to the session is granted to all ECC2015 registered participants.
If you are participating in ECC2015, please visit our booth number 504. The ESO educational programme 2016 and information about our activities, including ABC3, will be available there.


Session held within
 

Faculty list


FACULTY

M. Aapro
, Clinique de Genolier, CH
R. Bergström, European Federation of Pharmaceutical Industries and Associations, Brussels, BE
P. Cornes, Clinical Outcomes Group, Bristol, UK
F. De Lorenzo, European Cancer Patient Coalition, Brussels, BE
F.A. Peccatori, European School of Oncology, Milan, IT
M. Piccart, Jules Bordet Institute, Brussels, BE
E. Sharpe, The Institute of Cancer Research, London, UK

Programme

SESSION PROGRAMME

Saturday, 26 September 2015
16:45-18:15 (Hall A5)
   
 16:45 Economics for oncologists: The reality of costs
P. Cornes, UK
 17:00 Concerns or solutions: The ESO Innovation Task Force
M. Aapro, CH
 17:10 The World Oncology Forum: Treat the treatable
F.A. Peccatori, IT
 17:20 The ESMO initiative on affordable drugs
M. Piccart, BE
 17:35 Affordability of innovative cancer medicine: A research perspective
E. Sharpe, UK
 17:50 Industry perspective on valuation of innovation 
R. Bergström, BE
 18:00 Roundtable discussion with the audience
 18:15
 End of the session
                             

Follow us